Rx-Dr exists for the patient who's been told eat less, move more for fifteen years. Primary care said maybe next year. Insurance denied the prior-auth. By the time they reach our intake, they already know more about GLP-1 protocols than most front-desk schedulers.
Weight is not a willpower diagnosis. The medication for it is one of the most-studied drug classes in modern medicine. Access shouldn't take nine phone calls.
No upsell at checkout. No retargeting flow that preys on month-four discouragement. No data handed to a third-party broker.
Our providers can decline, pause, or switch you. They get paid the same either way.
Most weight-loss companies optimize the first sale. We optimize the eighth refill — the one where the protocol either holds or doesn't.
One medication, one plan, one price. Nothing bolted on at the last step.
A clinician licensed in your state reads your intake. Software just assembles the chart.
Per-month price is on the product page. No consult fee. No activation. No surprises.
The same provider who started you titrates you through the plateau.
Compounded GLP-1s aren't covered. We don't waste your two weeks finding that out.
Times are typical, not promises.
Pre-screened automatically for state + contraindications.
A clinician licensed in your state reads the chart. Approve, request info, or decline.
E-Rx routes to the partner pharmacy with the audit trail attached.
Cold-chain packaging from a 503A pharmacy. Lowest titration dose first.
Same provider escalates, pauses, or switches you. Every refill is reviewed.
We add to the catalog when our providers want to prescribe the next entrant for a family member.
The active ingredient was studied in STEP-1, a trial of the FDA-approved product: ~15% mean body-weight reduction at 68 weeks. Compounded formulations were not studied in that trial.
The active ingredient was studied in SURMOUNT-1, a trial of the FDA-approved product: ~21% mean body-weight reduction at 72 weeks. Compounded formulations were not studied in that trial.
Important information about compounded medications
Compounded Semaglutide / Methylcobalamin and Compounded Tirzepatide / Methylcobalamin are prepared by a state-licensed 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. They are not Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and are not generic equivalents of those products. Prescriptions are issued only when a licensed provider determines a compounded medication is clinically appropriate for you. Product images are for illustration only — your dispensed medication is prepared, labeled, and dispensed by the compounding pharmacy, whose name appears on your prescription label. Individual results vary.
We built the practice we wanted to staff — not the funnel a marketing team would draw.